News

FLAB nanoscaffold combines cancer diagnosis and therapy
Theranostic platform combines cisplatin, nanoparticles, and fluorescence to improve treatment delivery and diagnosis.

CAR-T in resource-limited regions: challenges and perspectives for Brazil
CAR-T cell therapy has been transforming the treatment of hematological neoplasms, but its implementation in countries such as Brazil still faces significant barriers.

Jornal da USP: USP professors win the 7th Carolina Bori Science & Women Award
This content is in Portuguese.

Jornal da USP: Study investigates the relationship between longevity among Brazilian supercentenarians and genetic admixture
This content is in Portuguese.

Icesp: Get to know the Icesp Recombinant Viral Vectors Core Facility: a differentiated technology offering for research
This content is in Portuguese.

CAPES agreements take effect and Brazilian researchers can now publish without paying fees
Agreements with major international publishers eliminate article processing charges and expand open-access publishing for Brazilian institutions.

FMRP-USP: Faculdade de Medicina de Ribeirão Preto inaugurates new Center for Research in Biomedical Sciences
This content is in Portuguese.

Jornal da USP: Study shows that breastfeeding helps protect against breast cancer
This content is in Portuguese.

Multi-Modal Machine Learning in Biomedicine course reaches its second edition
The course will be offered from January 20 to April 30, 2026. Course registrations will close at noon on January 19, 2026.

Jornal da USP: Self-sampling can be an ally in the prevention of cervical cancer
This content is in Portuguese.

Precision Oncology Symposium brought together USP scientists to discuss advances and plan the next steps of the C2PO
With lectures, collaborative activities, and a scientific ideation workshop, the event promoted the integration of competencies across USP, presented ongoing research, established the basis for the strategic planning of the C2PO, and reinforced the center’s role as an articulator of precision oncology initiatives within the university.
